EC
KRSA

EcoR1 Capital’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

EcoR1 Capital’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,473
Closed -$4.93M – 81
2021
Q3 		$4.93M Hold
11,473
– – 0.17% 42
2021
Q2 		$6.26M Hold
11,473
– – 0.23% 39
2021
Q1 		$4.48M Hold
11,473
– – 0.2% 43
2020
Q4 		$4.92M Sell
11,473
-8,115
-41% -$553K 0.26% 41
2020
Q3 		$16.7M Hold
19,588
– – 1.19% 21
2020
Q2 		$16.2M Hold
19,588
– – 1.2% 23
2020
Q1 		$7.27M Buy
19,588
+6,652
+51% +$475K 0.76% 31
2019
Q4 		$4.93M Buy
12,936
+7,392
+133% +$690K 0.44% 35
2019
Q3 		$9.41M Hold
5,544
– – 1.19% 20
2019
Q2 		$8.89M Buy
+5,544
New +$1.57M 0.9% 22

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital's KRSA Position: Q4 2021 in Review

EcoR1 Capital sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2021, closing a stake of 11,473 shares — an estimated $4.93M sold.

EcoR1 Capital first reported a position in KRSA in Q2 2019 and held it in 10 quarters. The position peaked at $16.7M in Q3 2020. 51 funds tracked by Wall St. Rank hold KRSA as of Q4 2021.

  • EcoR1 Capital reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • EcoR1 Capital sold 11,473 Korsana Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $4.93M.
  • EcoR1 Capital first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • EcoR1 Capital's Korsana Biosciences, Inc. Common Stock position peaked at $16.7M in Q3 2020.
  • 51 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2021.

Based on EcoR1 Capital's 13F filing for Q4 2021, filed 14 Feb 2022.